ロード中...
The steady progress of targeted therapies, promising advances for lung cancer
Lung cancer remains one of the most complex and challenging cancers, being responsible for almost a third of all cancer deaths. This grim picture seems however to be changing, for at least a subset of lung cancers. The number of patients who can benefit from targeted therapies is steadily increasing...
保存先:
| 出版年: | Ecancermedicalscience |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cancer Intelligence
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898931/ https://ncbi.nlm.nih.gov/pubmed/27350784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.638 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|